Table 3 Differences in characteristics of patients on antihypertensive medications, by hypertension control status
Characteristic (unit) | Uncontrolled Hypertension (n = 4340) | Controlled Hypertension (n = 493) | p value |
|---|---|---|---|
| Â | n (%) | Â | |
Female | 3175 (73.2) | 339 (68.8) | 0.038 |
Age (years) | Â | Â | <0.0001 |
 25–34 | 353 (8.1) | 113 (22.9) |  |
 35–44 | 786 (18.1) | 103 (20.9) |  |
 ≥45 | 3201 (73.8) | 277 (56.2) |  |
BMI (kg/m2) | Â | Â | <0.0001 |
 <18.5 | 328 (7.6) | 47 (9.5) |  |
 18.5-24.9 | 1634 (37.6) | 220 (44.6) |  |
 25.0-29.9 | 1000 (23.0) | 104 (21.1) |  |
 ≥30 | 831 (19.1) | 59 (12.0) |  |
 History of hypertension | 1747(40.2) | 102 (20.7) | <0.0001 |
Treatments | Â | Â | Â |
 atenelol | 439 (10.1) | 38 (7.7) | 0.09 |
 enalapril | 28 (0.65) | 5 (1.0) | 0.35 |
 furosemide | 2007 (46.2) | 225 (45.6) | 0.80 |
 hydralazine | 45 (1.0) | 6 (1.2) | 0.71 |
 hydrochlorothiazide amiloride | 34 (0.78) | 7 (1.4) | 0.14 |
 methyldopa | 205 (4.7) | 17 (3.4) | 0.20 |
 nifedipine | 2259 (52.0) | 135 (27.4) | <0.0001 |
 propranolol | 560 (12.9) | 96 (19.5) | 0.0001 |